AW
NAMS icon

Avion Wealth’s NewAmsterdam Pharma NAMS Stock Holding History

Avion Wealth’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4K Buy
+200
New +$5.53K ﹤0.01% 841

Other funds holding NAMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mizuho Markets Cayman
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.12B AUM 114.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Peregrine Capital Management
Peregrine Capital Management Minneapolis, Minnesota $2.95B AUM 28.43% 1-Year Est. Return

Avion Wealth's NAMS Position: Q3 2026 in Review

Avion Wealth opened a new position in NewAmsterdam Pharma (NAMS) in Q3 2026: 200 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #841 among its holdings.

70 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • Avion Wealth held 200 shares of NewAmsterdam Pharma worth $4K as of Q3 2026.
  • NewAmsterdam Pharma was a new Avion Wealth position in Q3 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #841 holding.
  • 70 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.